NCT05812716

Brief Summary

The goal of this clinical trial is to evaluate an online resilience intervention with healthcare professionals. Participants will receive a 6-week online intervention addressing resilience and stress with a specific focus on self-care and self-compassion. The main question is whether the intervention is effective in increasing resilience.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 14, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 20, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 4, 2024

Completed
Last Updated

October 23, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

February 27, 2023

Last Update Submit

October 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change of Resilience measured with stressor reactivity score (Kalisch et al., 2015, 2021)

    Stressor reactivity score (Kalisch et al., 2015, 2021): Stressor reactivity can be approximated by relating self-reported mental-health problems to the corresponding stressor exposure within the same timeframe (for scales for mental health problems and stressor exposure, see secondary outcomes). The stressor reactivity (SR) score will be computed as an individual score against normal stressor reactivity (see Kalisch et al., 2021), where normal stressor reactivity is the regression line of average mental health problems against average stressor exposure across all time points in the trial population and one's individual SR score at any time point is the distance to the regression line. The inverse of the SR score is considered an approximative index of outcome-based resilience. Therefore, a lower SR score indicates higher resilience. Change calculated between time points named in time frame, for details, see statistical analysis plan.

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

Secondary Outcomes (32)

  • Change in Resilience measured with Brief Resilience Scale (BRS; Chmitorz et al., 2018)

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

  • Change in Mental Health measured with General Health Questionnaire (GHQ-12; Schrnitz et al., 1999)

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

  • Change in Stress measured with Perceived Stress Scale (PSS-2+2; Schäfer et al., in preparation)

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

  • Change in Well-being measured with WHO-5 Well-Being Index (Brähler et al., 2007)

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

  • Change in Anxiety measured with Generalized Anxiety Disorder-7 (GAD-7; Löwe et al., 2002)

    baseline (pre), 4 weeks (intermediate), 6-8 weeks (post), 3 months (first follow-up), 6 months (second follow-up), 12 months (third follow-up)

  • +27 more secondary outcomes

Other Outcomes (28)

  • Attitudes towards Psychological Online Interventions measured with Attitudes towards Psychological Online Interventions Questionnaire (APOI; Schröder et al., 2015)

    baseline (pre)

  • Personality measured with Big Five Inventory-10 (BFI-10; Rammstedt et al., 2017)

    baseline (pre)

  • Sociodemographic Variables

    baseline (pre)

  • +25 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Participants in the intervention group will gain access to the 6-week online resilience intervention "resiLIR Healthcare Professionals".

Behavioral: resiLIR Healthcare Professionals

Waitlist control group

NO INTERVENTION

Participants will receive the intervention after the first follow up-assessment (3 months post-intervention of the intervention group).

Interventions

Weeks 1 and 2: Theoretical part on stress, resilience, self-care, and self-compassion Weeks 3 to 6: Training phase of a weekly introduced practical exercise (reflection on living with ease, self-compassionate body scan, planning of positive activities, self-compassionate letter). This phase additionally includes smartphone reminders to apply the exercises in everyday life.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Fluent in German language
  • Access to web-enabled devices (tablet/laptop/computer)
  • Smartphone with internet access
  • Trained and employed as health care professionals

You may not qualify if:

  • Acute mental health crisis (e.g., suicidality)
  • Psychiatric/psychotherapeutic treatment
  • Neurodegenerative disease(s)
  • Diagnosis of schizophrenia or other psychotic disorders, bipolar disorder, post-traumatic stress disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Leibniz Institute for Resilience Research gGmbH

Mainz, Rhineland-Palatinate, 55122, Germany

Location

Study Officials

  • Oliver Tüscher

    Leibniz Institute of Resilience Research

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Waitlist control design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2023

First Posted

April 14, 2023

Study Start

June 20, 2023

Primary Completion

July 4, 2024

Study Completion

July 4, 2024

Last Updated

October 23, 2024

Record last verified: 2024-10

Locations